European Patent Office

T 1507/11 (Bryostatin with alpha-tocopherol/BRNI) of 04.08.2016

European Case Law Identifier
ECLI:EP:BA:2016:T150711.20160804
Date of decision
4 August 2016
Case number
T 1507/11
Online on
23 September 2016
Petition for review of
-
Application number
05784925.9
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
COMBINATIONS OF PKC ACTIVATORS AND PKC INHIBITORS FOR ALZHEIMER'S DISEASE TREATMENT AND COGNITIVE ENHANCEMENT
Applicant name
Blanchette Rockefeller Neurosciences Institute
Opponent name
-
Board
3.3.01
Headnote
-
Relevant legal provisions
European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(1)
Keywords
Inventive step (no): obvious combination of active ingredients
Auxiliary request 4: admitted (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed.